Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 - Type I Interferon Pathway.

Cardiol Cardiovasc Med · 2022 · PMC9450995 · PMID 36081846

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

High dose HCQ-treated mice tended to have a smaller IS compared to the low and moderate dose HCQ-treated mice, but the difference did not reach statistical significance ( Figure 5A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.